Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.
作者信息
Smetana Gerald W
出版信息
J Gen Intern Med. 2012 Jun;27(6):618-20. doi: 10.1007/s11606-012-2020-x.
Abstract
摘要
相似文献
1
Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.
J Gen Intern Med. 2012 Jun;27(6):618-20. doi: 10.1007/s11606-012-2020-x.
2
Better compliance to antihypertensive medications reduces cardiovascular risk.
J Hypertens. 2011 Mar;29(3):610-8. doi: 10.1097/HJH.0b013e328342ca97.
3
Pharmacologic Treatment of Pediatric Hypertension.
Curr Hypertens Rep. 2016 Apr;18(4):32. doi: 10.1007/s11906-016-0639-4.
4
Newer antihypertensive agents in pregnancy.
Med J Aust. 1992 Mar 2;156(5):304-5. doi: 10.5694/j.1326-5377.1992.tb139781.x.
5
Parathyroidectomy for Patients With Primary Hyperparathyroidism and Associations With Hypertension.
JAMA Surg. 2020 Jan 1;155(1):32-39. doi: 10.1001/jamasurg.2019.3950.
6
Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.
Arch Intern Med. 2002 Nov 11;162(20):2325-32. doi: 10.1001/archinte.162.20.2325.
7
Antihypertensive therapy and coronary prevention.
J Cardiovasc Pharmacol. 1990;16 Suppl 6:S23-7.
8
[Status of ongoing controlled clinical trials on hypertension].
Tidsskr Nor Laegeforen. 1996 Jan 10;116(1):61-3.
9
Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications.
J Manag Care Spec Pharm. 2014 Sep;20(9):905-11. doi: 10.18553/jmcp.2014.20.9.905.
10
Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension.
J Adolesc Health. 2014 Jul;55(1):73-8. doi: 10.1016/j.jadohealth.2013.12.006. Epub 2014 Feb 1.
引用本文的文献
1
Triamterene in the Treatment of Hypertension: More Than Just Potassium Sparing?
J Gen Intern Med. 2016 Jan;31(1):7-8. doi: 10.1007/s11606-015-3515-z.
2
ACE inhibitors versus ARBs versus DRIs: a systematic update.
J Gen Intern Med. 2012 Dec;27(12):1585; author reply 1586. doi: 10.1007/s11606-012-2212-4.
本文引用的文献
1
In brief: aliskiren trial terminated.
Med Lett Drugs Ther. 2012 Jan 23;54(1382):5.
2
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.
J Gen Intern Med. 2012 Jun;27(6):716-29. doi: 10.1007/s11606-011-1938-8. Epub 2011 Dec 7.
3
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.
BMJ. 2011 Apr 26;342:d2234. doi: 10.1136/bmj.d2234.
4
Effect of valsartan on the incidence of diabetes and cardiovascular events.
N Engl J Med. 2010 Apr 22;362(16):1477-90. doi: 10.1056/NEJMoa1001121. Epub 2010 Mar 14.
5
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
Blood Press. 2009;18(6):308-47. doi: 10.3109/08037050903450468.
6
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20.
7
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. doi: 10.7326/0003-4819-151-4-200908180-00135. Epub 2009 Jul 20.
8
First-line drugs for hypertension.
Cochrane Database Syst Rev. 2009 Jul 8(3):CD001841. doi: 10.1002/14651858.CD001841.pub2.
9
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors.
PLoS Med. 2009 Apr 28;6(4):e1000058. doi: 10.1371/journal.pmed.1000058.
10
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29.
Zotero 插件